|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.42 USD | +2.78% |
|
-13.67% | - |
| 06-29 | Avalyn Pharma Inc.(NasdaqGS:AVLN) added to Russell 2000 Index | CI |
| 06-29 | Avalyn Pharma Inc.(NasdaqGS:AVLN) added to Russell 2000 Value Benchmark | CI |
| Market Cap | 1.23B 1.07B 989M 916M 1.74B 116B 1.77B 11.85B 4.61B 57.42B 4.6B 4.5B 198B | P/E 2026 * |
-9.9x | P/E 2027 * | -11.8x |
|---|---|---|---|---|---|
| Enterprise Value | 1.23B 1.08B 995M 922M 1.75B 117B 1.78B 11.93B 4.64B 57.77B 4.63B 4.53B 200B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
100% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Avalyn Pharma Inc.
| 1 day | +2.78% | ||
| 1 week | -13.67% | ||
| Current month | -13.67% | ||
| 1 month | +5.03% |
| 1 week | 27.33 |  | 31.08 |
| 1 month | 26.02 | | 33.32 |
| Current year | 24.15 | | 33.32 |
| 1 year | 24.15 | | 33.32 |
| 3 years | 24.15 | | 33.32 |
| 5 years | 24.15 | | 33.32 |
| 10 years | 24.15 | | 33.32 |
| Manager | Title | Age | Since |
|---|---|---|---|
Lyn Baranowski
CEO | Chief Executive Officer | 50 | 2022-10-13 |
Douglas Carlson
DFI | Director of Finance/CFO | 47 | 2024-04-30 |
Howard Lazarus
CTO | Chief Tech/Sci/R&D Officer | 60 | 2023-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Ketan Patel
BRD | Director/Board Member | 51 | 2017-02-28 |
Tiba Aynechi
BRD | Director/Board Member | 50 | 2017-02-28 |
Lyn Baranowski
BRD | Director/Board Member | 50 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 04-30 | F-Prime, Inc.
| Conversion | Company | -225,843 | 1.1116% | |
| 04-30 | F-Prime, Inc.
| Conversion | Company | -727,585 | 1.4654% | |
| 04-30 | Novo Holdings A/S (Investment Company)
| Conversion | Company | 67,914,626 | 153.2645% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.78% | -13.67% | - | - | 1.23B | |
| -0.10% | +0.10% | +74.33% | +133.26% | 57.73B | |
| -3.80% | -6.24% | +67.04% | +86.36% | 54.69B | |
| +0.38% | +1.33% | -14.32% | -11.76% | 23.75B | |
| +1.17% | +5.83% | +16.39% | +468.18% | 24.18B | |
| -2.70% | +4.25% | +40.38% | -3.72% | 19.82B | |
| +3.78% | +5.65% | +44.99% | -26.23% | 17.14B | |
| +3.46% | +17.72% | +206.66% | +364.07% | 16.75B | |
| -1.81% | +18.00% | +41.99% | - | 15.57B | |
| +2.79% | +4.91% | +29.26% | +195.60% | 13.96B | |
| Average | +0.59% | +3.88% | +56.30% | +150.72% | 24.48B | |
| Weighted average by Cap. | -0.38% | +3.22% | +57.92% | +139.30% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -108M -94.75M -87.32M -80.94M -154M -10.28B -156M -1.05B -407M -5.07B -407M -398M -17.53B | -110M -96.08M -88.55M -82.08M -156M -10.42B -158M -1.06B -413M -5.14B -412M -403M -17.78B |
| Net Debt | 7.65M 6.7M 6.17M 5.72M 10.86M 726M 11.03M 74M 28.78M 358M 28.73M 28.1M 1.24B | -453M -396M -365M -339M -643M -42.99B -653M -4.38B -1.7B -21.21B -1.7B -1.66B -73.32B |
Employees
50
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-07 | US$28.42 | +2.78% | 395,649 |
| 26-07-06 | US$27.65 | -7.00% | 518,809 |
| 26-07-02 | US$29.73 | -1.46% | 582,507 |
| 26-07-01 | US$30.17 | -8.35% | 785,936 |
| 26-06-30 | US$32.92 | +6.19% | 540,854 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
28.42USD
Average target price
59.00USD
Spread / Average Target
+107.60%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AVLN Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
